I will be interested how Artes (my personal investment) with its permanent wrinkle filler will compete against all the temporary fillers. Reducing the number of needle injections for HIV patients may be good for patients and providers alike. (Having been personally stuck twice with needles in AIDS patients)
Market Data 
Markets 
AI
